DEXCOM, INC. Additional Paid in Capital, Common Stock
DEXCOM, INC. (DXCM) had Additional Paid in Capital, Common Stock of $2.38 billion as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-07-30
- 2026-06-30: Additional Paid in Capital, Common Stock $2.38B.
- 2026-03-31: Additional Paid in Capital, Common Stock $2.34B.
- 2025-12-31: Additional Paid in Capital, Common Stock $2.28B.
- 2025-09-30: Additional Paid in Capital, Common Stock $2.25B.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $2.38B 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $2.34B 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $2.28B 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $2.25B 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $2.19B 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $2.14B 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $2.09B 10-K · filed 2026-02-12 | |
| 2024-09-30 | $2.05B 10-Q · filed 2024-10-24 | |
| 2024-06-30 | $1.99B 10-Q · filed 2024-07-25 | |
| 2024-03-31 | $2.51B 10-Q · filed 2024-04-25 | |
| 2023-12-31 | $3.51B 10-K · filed 2025-02-18 | |
| 2023-09-30 | $3.62B 10-Q · filed 2023-10-26 | |
| 2023-06-30 | $2.27B 10-Q · filed 2023-07-27 | |
| 2023-03-31 | $2.31B 10-Q · filed 2023-04-27 | |
| 2022-12-31 | $2.26B 10-K · filed 2024-02-08 | |
| 2022-09-30 | $2.07B 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $2.03B 10-Q · filed 2022-07-28 | |
| 2022-03-31 | $2.00B 10-Q · filed 2022-04-28 | |
| 2021-12-31 | $2.11B 10-K · filed 2023-02-09 | $2.50B 10-K · filed 2022-02-14 |
| 2021-09-30 | $2.32B 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $2.19B 10-Q · filed 2021-07-29 | |
| 2021-03-31 | $2.16B 10-Q · filed 2021-04-29 | |
| 2020-12-31 | $1.73B 10-K · filed 2023-02-09 | $2.13B 10-K · filed 2021-02-11 |
| 2020-09-30 | $2.15B 10-Q · filed 2020-10-27 | |
| 2020-06-30 | $2.08B 10-Q · filed 2020-07-28 | |
| 2020-03-31 | $1.71B 10-Q · filed 2020-04-28 | |
| 2019-12-31 | $1.68B 10-K · filed 2021-02-11 | |
| 2019-09-30 | $1.65B 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $1.62B 10-Q · filed 2019-07-31 | |
| 2019-03-31 | $1.59B 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $1.56B 10-K · filed 2020-02-13 | |
| 2018-09-30 | $1.18B 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $1.15B 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $1.12B 10-Q · filed 2018-05-02 | |
| 2017-12-31 | $1.09B 10-K · filed 2019-02-21 | |
| 2017-09-30 | $1.05B 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $1.02B 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $942.30M 10-Q · filed 2017-05-02 | |
| 2016-12-31 | $905.70M 10-K · filed 2018-02-27 | |
| 2016-09-30 | $876.00M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $841.80M 10-Q · filed 2016-08-02 | |
| 2016-03-31 | $806.00M 10-Q · filed 2016-04-27 | |
| 2015-12-31 | $776.80M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $750.40M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $685.30M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $659.50M 10-Q · filed 2015-04-29 | |
| 2014-12-31 | $638.00M 10-K · filed 2016-02-23 | |
| 2014-09-30 | $614.10M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $593.60M 10-Q · filed 2014-08-06 | |
| 2014-03-31 | $577.90M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $559.50M 10-K · filed 2015-02-25 | |
| 2013-09-30 | $547.50M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | $539.10M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $530.30M 10-Q · filed 2013-05-01 | |
| 2012-12-31 | $522.60M 10-K · filed 2014-02-20 | |
| 2012-09-30 | $517.42M 10-Q · filed 2012-11-01 | |
| 2012-06-30 | $511.21M 10-Q · filed 2012-08-06 | |
| 2012-03-31 | $504.77M 10-Q · filed 2012-05-02 | |
| 2011-12-31 | $495.60M 10-K · filed 2013-02-21 | $495.63M 10-K · filed 2012-02-23 |
| 2011-09-30 | $491.96M 10-Q · filed 2011-11-02 | |
| 2011-06-30 | $487.20M 10-Q · filed 2011-08-03 | |
| 2010-12-31 | $407.38M 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |